Cyclobenzaprine Street Value: Low Abuse Potential, Not a Drug of Diversion

Cyclobenzaprine (Flexeril) has negligible street value and is not a significant drug of abuse or diversion.

Reasons

• Muscle relaxant (central α2-adrenergic agonist), not euphoriant
• Sedation is primary effect — unpleasant at high doses (anticholinergic: dry mouth, confusion, urinary retention)
• No reinforcing dopamine surge; low addiction liability
• Schedule: Not controlled (US); some states monitor via PDMP

Clinical Context

Prescribed short-term (2–3 weeks) for acute muscle spasm. Misuse occurs mainly in polydrug contexts (potentiating opioids/benzodiazepines), not as primary drug of abuse.

If you or someone you know is misusing prescription medications, contact SAMHSA Helpline: 1-800-662-HELP (4357).